Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kaasinen, V.
Right arrow Articles by Rinne, J. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kaasinen, V.
Right arrow Articles by Rinne, J. O.
Neurology 2000;54:1482-1487
© 2000 American Academy of Neurology
Articles

Extrastriatal dopamine D2 and D3 receptors in early and advanced Parkinson’s disease

V. Kaasinen, MD, K. Någren, PhD, J. Hietala, MD, PhD, V. Oikonen, MSc, H. Vilkman, MD, L. Farde, MD, PhD, C. Halldin, PhD and J. O. Rinne, MD, PhD

From the Departments of Neurology (Drs. Kaasinen and Rinne), Psychiatry (Dr. Hietala), and Pharmacology (Dr. Vilkman), University of Turku, and the Turku PET Centre (Drs. Någren and Oikonen), Turku, Finland; and the Department of Clinical Neuroscience (Drs. Farde and Halldin), Karolinska Hospital, Stockholm, Sweden.

Address correspondence and reprint requests to Dr. Valtteri Kaasinen, Department of Neurology, University of Turku, Turku FIN-20520, Finland; e-mail: valtteri.kaasinen{at}pet.tyks.fi

OBJECTIVE: To investigate whether dopamine D2 and D3 receptor subtypes (D2/3Rs) outside the caudate-putamen are affected in PD.

BACKGROUND: Alterations in striatal D2-like dopamine receptors in PD have been extensively demonstrated using PET, but there are no studies focusing on extrastriatal D2/3Rs.

METHODS: Fourteen unmedicated patients with idiopathic early PD with predominantly left-sided symptoms, 14 levodopa-medicated patients with advanced PD, and 20 normal age-matched controls were examined using PET. PET scanning was performed with a novel high-affinity D2/3R radioligand ([11C]FLB 457) and a PET scanner in three-dimensional mode.

RESULTS: In advanced PD, the binding potential of [11C]FLB 457 in the dorsolateral prefrontal cortex was decreased by 40% (p < 0.01), in the anterior cingulate cortex by 20% (p < 0.01), and in the medial thalamus by 17% (p < 0.05) compared with healthy controls. In early PD, the extrastriatal [11C]FLB 457 binding potentials were not significantly different compared with the control group. However, the binding potential in the anterior cingulate cortex (29%; p < 0.05) was higher in early PD compared with advanced PD.

CONCLUSIONS: These results imply that the D2/3 receptor subtypes outside the striatum are affected in advanced PD but not in the early stages of the disease, and that this receptor decline is present in the anterior cingulate cortex, the dorsolateral prefrontal cortex, and the thalamus.

Key words: PD—Dopamine receptors—D2 subtype—D3 subtype




This article has been cited by other articles:


Home page
 J. Neurosci.Home page
M. Argyelan, M. Carbon, M.-F. Ghilardi, A. Feigin, P. Mattis, C. Tang, V. Dhawan, and D. Eidelberg
Dopaminergic Suppression of Brain Deactivation Responses during Sequence Learning
J. Neurosci., October 15, 2008; 28(42): 10687 - 10695.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
K. Asanuma, C. Tang, Y. Ma, V. Dhawan, P. Mattis, C. Edwards, M. G. Kaplitt, A. Feigin, and D. Eidelberg
Network modulation in the treatment of Parkinson's disease
Brain, October 1, 2006; 129(10): 2667 - 2678.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
C. Scherfler, N. L. Khan, N. Pavese, L. Eunson, E. Graham, A. J. Lees, N. P. Quinn, N. W. Wood, D. J. Brooks, and P. P. Piccini
Striatal and cortical pre- and postsynaptic dopaminergic dysfunction in sporadic parkin-linked parkinsonism
Brain, June 1, 2004; 127(6): 1332 - 1342.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
D. Garcia-Borreguero, P. Odin, and C. Serrano
Restless legs syndrome and PD: A review of the evidence for a possible association
Neurology, September 23, 2003; 61(90063): S49 - 55.
[Abstract] [Full Text]

Home page
 NeurologyHome page
A. Feigin, M. F. Ghilardi, M. Carbon, C. Edwards, M. Fukuda, V. Dhawan, C. Margouleff, C. Ghez, and D. Eidelberg
Effects of levodopa on motor sequence learning in Parkinson's disease
Neurology, June 10, 2003; 60(11): 1744 - 1749.
[Abstract] [Full Text] [PDF]

Home page
 Arch NeurolHome page
W. G. Ondo, K. D. Vuong, and J. Jankovic
Exploring the Relationship Between Parkinson Disease and Restless Legs Syndrome
Arch Neurol, March 1, 2002; 59(3): 421 - 424.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
V. Kaasinen, E. Nurmi, A. Bruck, O. Eskola, J. Bergman, O. Solin, and J. O. Rinne
Increased frontal [18F]fluorodopa uptake in early Parkinson's disease: sex differences in the prefrontal cortex
Brain, June 1, 2001; 124(6): 1125 - 1130.
[Abstract] [Full Text] [PDF]

Home page
 Arch NeurolHome page
E. Friess, T. Kuempfel, J. Winkelmann, D. Schmid, M. Uhr, R. Rupprecht, F. Holsboer, and C. Trenkwalder
Increased Growth Hormone Response to Apomorphine in Parkinson Disease Compared With Multiple System Atrophy
Arch Neurol, February 1, 2001; 58(2): 241 - 246.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by AAN Enterprises, Inc.